Farallon Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $486K | Hold |
|
|||||
|
2025
Q2 | $418K | Hold |
|
|||||
|
2025
Q1 | $467K | Hold |
|
|||||
|
2024
Q4 | $338K | Hold |
|
|||||
|
2024
Q3 | $359K | Hold |
|
|||||
|
2024
Q2 | $322K | Hold |
|
|||||
|
2024
Q1 | $319K | Hold |
|
|||||
|
2023
Q4 | $318K | Sell |
|
|||||
|
2023
Q3 | $8.78M | Sell |
|
|||||
|
2023
Q2 | $19.6M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $45.7M | Buy |
|
|||||
|
2019
Q3 | $8.1M | Buy |
|